|
|
|
Back to: Home
» Prescription
» Others
|
 |
|
|
|
|
|
Dynacirc CR (Isradipine)
|
|
 Only Available By Prescription
|
| Product Size |
Retail Price |
Our Price |
|
| Brand 2.5mg 30 capsule(s) |
$44.20 |
$34.00 |
 |
| Brand 5mg 30 tablets |
$118.30 |
$91.00 |
|
| Brand 5mg 90 tablets |
$335.40 |
$258.00 |
|
|
For multiple quantities , edit your quantity when you click on checkout or click BUY until you reach your required amount. |
|
|
|
Manufacturer:
Reliant
|
Description
This product will be shipped from our partner licensed pharmacy outside of Canada
This medicine is a calcium channel blocker used to treat high blood pressure. It may also be used to treat other conditions as determined by your doctor.
|
Cautions
DO NOT STOP USING THIS MEDICINE without first checking with your doctor. USING THIS MEDICINE ALONE, WITH OTHER MEDICINES, OR WITH ALCOHOL may lessen your ability to drive or to perform other potentially dangerous tasks. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to this medicine. BEFORE YOU BEGIN TAKING ANY NEW MEDICINE, either prescription or over-the-counter, check with your doctor or pharmacist. FOR WOMEN: IF YOU PLAN ON BECOMING PREGNANT, discuss with your doctor the benefits and risks of using this medicine during pregnancy. IT IS UNKNOWN IF THIS MEDICINE IS EXCRETED in breast milk. DO NOT BREAST-FEED while taking this medicine.
SIDE EFFECTS, that may go away during treatment, include dizziness, headache, feeling of warmth (flushing), diarrhea, or nausea. If they continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience fast or irregular heartbeat, swelling of ankles or hands, rash, or difficulty breathing. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.
|
*All prices are subject to change without notice and prior to shipping.
|
|
|
 |
|
|
There are no items in your cart
|
|
 |
|
|
|
|
©2012 www.CanadaMedicineShop.com. All rights reserved.
